GNI Group Ltd. (2160.T)
JPY 1828.0
(0.66%)
JPY 1828.0
(0.66%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 14.48 Billion JPY | 140.29% |
| 2022 | 2.15 Billion JPY | 1.01% |
| 2021 | 2.13 Billion JPY | -4.78% |
| 2020 | 2.18 Billion JPY | 42.25% |
| 2019 | 1.5 Billion JPY | 112.1% |
| 2018 | 557.39 Million JPY | 185.08% |
| 2017 | 261.03 Million JPY | 236.52% |
| 2016 | -191.2 Million JPY | 66.11% |
| 2015 | -585.69 Million JPY | -46.09% |
| 2014 | -241.94 Million JPY | 47.53% |
| 2013 | -740.29 Million JPY | -95.93% |
| 2012 | -435.72 Million JPY | -3.13% |
| 2011 | -359.5 Million JPY | -136.09% |
| 2010 | -135.87 Million JPY | 0.0% |
| 2008 | -754.5 Million JPY | 30.72% |
| 2007 | -1.09 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 496.93 Million JPY | -103.46% |
| 2024 Q1 | 954.1 Million JPY | -60.85% |
| 2023 Q2 | 5.62 Billion JPY | 1706.14% |
| 2023 Q3 | 1.77 Billion JPY | -68.45% |
| 2023 FY | - JPY | 140.29% |
| 2023 Q1 | 311.16 Million JPY | 540.39% |
| 2023 Q4 | -2.08 Billion JPY | -217.34% |
| 2022 Q1 | 648.63 Million JPY | 489.12% |
| 2022 Q3 | 809.83 Million JPY | 4.95% |
| 2022 Q4 | -70.65 Million JPY | -108.72% |
| 2022 FY | - JPY | 1.01% |
| 2022 Q2 | 771.62 Million JPY | 18.96% |
| 2021 Q3 | 634.9 Million JPY | -18.75% |
| 2021 Q1 | 888.33 Million JPY | 52.56% |
| 2021 Q2 | 781.39 Million JPY | -12.04% |
| 2021 FY | - JPY | -4.78% |
| 2021 Q4 | -166.69 Million JPY | -126.25% |
| 2020 Q1 | 499.22 Million JPY | 71.14% |
| 2020 Q2 | 542.41 Million JPY | 8.65% |
| 2020 Q3 | 621.31 Million JPY | 14.54% |
| 2020 Q4 | 582.27 Million JPY | -6.28% |
| 2020 FY | - JPY | 42.25% |
| 2019 Q3 | 465.93 Million JPY | -8.43% |
| 2019 Q1 | 334.88 Million JPY | 71.32% |
| 2019 FY | - JPY | 112.1% |
| 2019 Q2 | 508.82 Million JPY | 51.94% |
| 2019 Q4 | 291.69 Million JPY | -37.4% |
| 2018 Q2 | 332.23 Million JPY | 122.04% |
| 2018 Q3 | 337.35 Million JPY | 1.54% |
| 2018 Q1 | 149.62 Million JPY | -51.02% |
| 2018 FY | - JPY | 185.08% |
| 2018 Q4 | 195.47 Million JPY | -42.06% |
| 2017 Q1 | -72.96 Million JPY | -240.61% |
| 2017 FY | - JPY | 236.52% |
| 2017 Q3 | 104.37 Million JPY | 263.94% |
| 2017 Q2 | -63.66 Million JPY | 12.74% |
| 2017 Q4 | 305.51 Million JPY | 192.72% |
| 2016 Q1 | -123.5 Million JPY | 13.54% |
| 2016 Q2 | -110.14 Million JPY | 10.82% |
| 2016 FY | - JPY | 66.11% |
| 2016 Q4 | 51.89 Million JPY | 649.1% |
| 2016 Q3 | -9.45 Million JPY | 91.42% |
| 2015 FY | - JPY | -46.09% |
| 2015 Q2 | -111.83 Million JPY | 16.43% |
| 2015 Q1 | -133.83 Million JPY | -220.73% |
| 2015 Q4 | -142.84 Million JPY | 16.27% |
| 2015 Q3 | -170.6 Million JPY | -52.54% |
| 2014 Q3 | -104.41 Million JPY | 24.92% |
| 2014 FY | - JPY | 47.53% |
| 2014 Q4 | 110.85 Million JPY | 206.17% |
| 2014 Q1 | -150.74 Million JPY | 3.41% |
| 2014 Q2 | -139.07 Million JPY | 7.74% |
| 2013 FY | - JPY | -95.93% |
| 2013 Q4 | -156.07 Million JPY | 58.67% |
| 2013 Q1 | -118.3 Million JPY | 2.11% |
| 2013 Q2 | -120.06 Million JPY | -1.49% |
| 2013 Q3 | -377.58 Million JPY | -214.48% |
| 2012 Q1 | -137.48 Million JPY | -26.85% |
| 2012 Q4 | -120.85 Million JPY | -5.6% |
| 2012 Q3 | -114.44 Million JPY | -11.86% |
| 2012 FY | - JPY | -3.13% |
| 2012 Q2 | -102.3 Million JPY | 25.59% |
| 2011 Q1 | -106.98 Million JPY | -3154.13% |
| 2011 Q3 | -71.12 Million JPY | 11.58% |
| 2011 FY | - JPY | -136.09% |
| 2011 Q4 | -108.38 Million JPY | -52.38% |
| 2011 Q2 | -80.44 Million JPY | 24.81% |
| 2010 Q1 | -90.53 Million JPY | 0.0% |
| 2010 FY | - JPY | 0.0% |
| 2010 Q4 | 3.5 Million JPY | -80.7% |
| 2010 Q3 | 18.15 Million JPY | 121.26% |
| 2010 Q2 | -85.39 Million JPY | 5.68% |
| 2009 Q3 | -102.2 Million JPY | -3.99% |
| 2009 Q1 | -105.62 Million JPY | 27.41% |
| 2009 Q2 | -98.27 Million JPY | 6.95% |
| 2008 FY | - JPY | 30.72% |
| 2008 Q4 | -145.51 Million JPY | 36.48% |
| 2008 Q3 | -229.09 Million JPY | 18.79% |
| 2008 Q2 | -282.1 Million JPY | 0.0% |
| 2007 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 958.1 Million JPY | -1412.239% |
| PRISM BioLab Co.,LTD | -488.13 Million JPY | 3068.212% |
| Linical Co., Ltd. | 1.24 Billion JPY | -1061.675% |
| Trans Genic Inc. | 240.95 Million JPY | -5913.145% |
| MEDINET Co., Ltd. | -1.35 Billion JPY | 1168.609% |
| Soiken Holdings Inc. | -583.2 Million JPY | 2584.335% |
| Cytori Cell Research Institute, Inc. | -603.09 Million JPY | 2502.422% |
| AnGes, Inc. | -8.86 Billion JPY | 263.53% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | 1227.1% |
| Nxera Pharma Co., Ltd. | -7.39 Billion JPY | 295.821% |
| Immuno-Biological Laboratories Co., Ltd. | 128.1 Million JPY | -11209.915% |
| NanoCarrier Co., Ltd. | -863 Million JPY | 1778.887% |
| Carna Biosciences, Inc. | -1.09 Billion JPY | 1427.077% |
| CanBas Co., Ltd. | 53.65 Million JPY | -26905.635% |
| D. Western Therapeutics Institute, Inc. | -775.59 Million JPY | 1968.097% |
| RaQualia Pharma Inc. | -111.8 Million JPY | 13059.448% |
| Chiome Bioscience Inc. | -1.21 Billion JPY | 1295.704% |
| Kidswell Bio Corporation | -1.38 Billion JPY | 1149.288% |
| PeptiDream Inc. | 7.37 Billion JPY | -96.43% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 850.835% |
| Ribomic Inc. | -1.01 Billion JPY | 1530.955% |
| SanBio Company Limited | -4.52 Billion JPY | 420.194% |
| Healios K.K. | -3 Billion JPY | 581.835% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | 1342.835% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | 1140.064% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | 1133.437% |
| StemRIM | -2.03 Billion JPY | 813.031% |
| CellSource Co., Ltd. | 1.3 Billion JPY | -1009.029% |
| FunPep Company Limited | -952 Million JPY | 1621.932% |
| Kringle Pharma, Inc. | -888.76 Million JPY | 1730.222% |
| Stella Pharma Corporation | -723.85 Million JPY | 2101.618% |
| TMS Co., Ltd. | -937 Million JPY | 1646.296% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | 1968.579% |
| Cuorips Inc. | -518 Million JPY | 2897.064% |
| K Pharma,Inc. | 366.05 Million JPY | -3858.059% |
| Takara Bio Inc. | 8.02 Billion JPY | -80.568% |
| ReproCELL Incorporated | 8.24 Million JPY | -175628.235% |
| PhoenixBio Co., Ltd. | 87.93 Million JPY | -16376.146% |
| StemCell Institute Inc. | 534.35 Million JPY | -2611.46% |
| Japan Tissue Engineering Co., Ltd. | 244.81 Million JPY | -5818.286% |
| CellSeed Inc. | -836.51 Million JPY | 1832.04% |